Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507325 · ClinicalTrials.gov registry record
Sample Collection From Melanoma Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 131
- Enrollment target
NCT00507325: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00507325 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00507325 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 131 participants
- Enrollment target
Study Summary
The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find ways to improve treatment for melanoma and other cancers.
Interventions
- PROCEDURE Blood Sample
- PROCEDURE Tumor Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2006-06-13 |
| Est. Completion | 2022-08-01 |
Why NCT00507325 stopped before completion
NCT00507325 is an observational study that tracks outcomes without assigning an intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Blood Sample is the first listed.
NCT00507325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00507325 about?
NCT00507325 is a clinical study titled "Sample Collection From Melanoma Patients". The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find w...
What is the current status of trial NCT00507325?
This trial is currently terminated. The enrollment target is 131 participants. The study started on 2006-06-13. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT00507325?
The interventions under investigation include: Blood Sample (PROCEDURE), Tumor Sample (PROCEDURE).
Who is sponsoring clinical trial NCT00507325?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI